Fusion Genomics Corp.

We Take Advice Seriously

Dr. Rand

Kenneth H. Rand, M.D.

Dr. Rand received his undergraduate degree from Harvard University and his Medical Degree from Stanford University Medical School, where he also completed his residency training in Internal Medicine, and Fellowship in Infectious Diseases. He joined the faculty at the University of Florida in 1977 and has continuously practiced Infectious Diseases since then. He is board certified by the American Board of Pathology Special Certification in Medical Microbiology and has over 35 years experience as the Medical Director of the UFHealth Shands Hospital Clinical Microbiology and Virology laboratories. In his role as laboratory director and Professor of Pathology and Medicine, he has published 130 peer-reviewed papers with the most recent focus on rapid molecular testing and technology in the clinical laboratory. Dr. Rand offers a unique combination of expertise and experience in both the practice of clinical Infectious Diseases and hospital clinical laboratory based microbiology and molecular diagnostic testing.

Richard M. Anthony PhD

Dr. Anthony is a Molecular Biologist who specializes in molecular diagnostics. He has extensive experience in development of molecular tests for bacterial drug resistance, bacterial and fungal typing, and microarray-based diagnostics. His work as Research Coordinator for the tuberculosis research group in KIT Biomedical Research is directed towards improving tuberculosis diagnostics.

Poul Sorensen MD, PhD, Co-Founder, Medical Advisor

Dr. Sorensen uses a combination of genetic and biochemical approaches to identify and discover proteins that are specifically altered in childhood cancers and adult breast tumours. His initial discoveries have been translated by FUSION GENOMICS into new diagnostic tests for specific tumours, and have advanced our understanding of how the involved proteins transmit signals that cause cells to become cancerous. Dr. Sorensen is also the Chair of the Translational Research Committee of the Children’s Oncology Group (COG), the largest pediatric oncology clinical trials network in the world.

Dr. Sam Chorlton

Sam Chorlton

Sam Chorlton is a board-certified medical microbiologist and CEO of BugSeq Bioinformatics. After completing medical microbiology residency at the University of British Columbia, Sam founded BugSeq Bioinformatics, a sequencing analysis company for clinical and public health labs. In this capacity, he oversees analysis for over 1000 laboratories, including hospital, state and national labs. He has served as PI or investigator on projects for the CDC and BARDA, including the development of rapid metagenomic and biothreat sequencing assays.